Filter
271
Filtered Results: 271
Text search:
Ministry
of
Health
[Kenya],
National
AIDS
and
STI
Control
Programme
(NASCOP)
Featured
Recommendations
18
New Publications
83
Language
Document type
No document type
182
Guidelines
43
Studies & Reports
23
Strategic & Response Plan
9
Manuals
6
Training Material
3
Fact sheets
3
Situation Updates
1
Infographics
1
Countries / Regions
Kenya
79
Nigeria
14
Ethiopia
9
Lesotho
8
Malawi
7
Uganda
7
Global
5
Tanzania
5
Zambia
5
Rwanda
4
Africa
3
Bangladesh
3
South Africa
3
Botswana
3
Ghana
2
Sierra Leone
2
Zimbabwe
2
Mozambique
2
Cambodia
2
Thailand
1
Ukraine
1
Benin
1
Senegal
1
Haiti
1
Asia
1
Russia
1
Namibia
1
South Sudan
1
India
1
Myanmar / Burma
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
134
Clinical Guidelines
28
Women & Child Health
11
Public Health
8
Capacity Building
5
Key Resources
2
Toolboxes
HIV
92
TB
13
Caregiver
5
Pharmacy
5
AMR
3
Mental Health
2
COVID-19
2
Disability
1
NCDs
1
Malaria
1
Conflict
1
Safety and efficacy of long-acting injectable lenacapavir as pre-exposure prophylaxis to reduce the risk of HIV acquisition: a systematic review
recommended
New
Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. Web Annex B
Bull World Health Organ 2015;93:457–467 | doi: http://dx.doi.org/10.2471/BLT.14.147215
Submitted to The Lesotho National Federation of Disabled (LNFOD)
Technical Update
HIV Treatment
July 2017
Practical Guidance for collaborative interventions
Based on further analysis of the 2004 Kenya Service Provision Assessment Survey
Offering additional pre-exposure prophylaxis (PrEP) choices has the potential to increase uptake and effective use of PrEP, and of HIV prevention overall, as it allows people to choose a method that they prefer.
In this guideline, WHO recommends an offering long-acting injectable lenacapavir (LEN...
Guidelines on post-exposure prophylaxis for HIV and the use of co-trimoxazole prophylaxis for HIV-related infections among adults, adolescents, and children: recommendations for a public health approach : December 2014 supplement to the 2013 Consolidated guidelines on the use of antiretroviral drugs...
Men lag behind women regarding use of HIV services and represent the majority of individuals living with uncontrolled HIV, advanced HIV, and who experience HIV-related mortality. Men (15+) globally are less likely than women (15+) to know their HIV status (83% for men vs 91% for women), be on antire...
Findings from a cross-sectional qualitative study of HIV vulnerabilities among People Who Inject Drugs and their sex partners in Bihar and Manipur, India. The study is one of the first qualitative comparative studies to seek an in-depth understanding of the vulnerabilities to HIV acquisition among P...
Significant progress has been made in the eradication of three priority diseases in the African Region, as a result of extensive collaboration between the Regional Office, WHO country offices and countries. For example, in August 2020, the region was certified free of wild poliovirus. In the area of...
Module 2
Community Educators and Advocates
July 2017
Module 2: Community educators and advocates. Community educators and advocates are needed to increase awareness about PrEP in their communities. This module provides information on PrEP that should be considered in community-led activities ...
Module 12:
Adolescents and young adults
July 2018
Module 12: Adolescents and young adults. This module is for people who are interested in providing PrEP services to older adolescents and young adults who are at substantial risk for HIV. It provides information on: factors that influence HIV...
Module 9
Strategic planning
July 2017
Module 9: Strategic planning. As WHO recommends offering PrEP to people at substantial HIV risk, this module offers public health guidance for policy-makers on how to prioritize services, in order to reach those who could benefit most from PrEP, and in wh...
Antimicrobial resistance (AMR) is an important public health concern shared by developed and developing countries. In developing countries the burden of infectious diseases is greater and exacerbated by limited access to, and availability and affordability of, antimicrobials required to treat infect...
